ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: Investment by Quintiles, Placement of 225 mi, page-7

  1. 512 Posts.
    re: Ann: Investment by Quintiles, Placement o... Two wasted years. Now selling 50% of the company at rock bottom prices. This is a terrible result for investors thrust upon us by a board and management who should be doing a better job.

    If Quintiles are doing the PII trial then that's outrageous. They fork out $2.3M to ensure they get $25M in fees, plus they get what is in effect a call option on a successful trial.

    I would have preferred to see Quintiles get up to 40% of the company in return for doing the trials. Less dilution and less conflict. Of course there are many other options I'd have preferred even more.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $2.733K 832.4K

Buyers (Bids)

No. Vol. Price($)
32 45274833 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126718541 16
View Market Depth
Last trade - 15.57pm 09/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.